Cargando…

Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin”

Background: Enterococcus faecalis is responsible for a large variety of severe infections. This study is a case series reporting our experience in the treatment of E. faecalis invasive infections with ampicillin in combination with ceftobiprole (ABPR). Methods: We retrospectively analyzed all the me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giuliano, Simone, Angelini, Jacopo, D’Elia, Denise, Geminiani, Monica, Barison, Roberto Daniele, Giacinta, Alessandro, Sartor, Assunta, Campanile, Floriana, Curcio, Francesco, Cotta, Menino Osbert, Roberts, Jason A., Baraldo, Massimo, Tascini, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215339/ https://www.ncbi.nlm.nih.gov/pubmed/37237782 http://dx.doi.org/10.3390/antibiotics12050879

Ejemplares similares

1112. Ceftobiprole for the Treatment of Invasive Enterococcus faecalis Infections: Ampicillin, "Should I Stay or Should I Go?"
por: Giuliano, Simone, et al.
Publicado: (2023)

Impact of PBP4 Alterations on β-Lactam Resistance and Ceftobiprole Non-Susceptibility Among Enterococcus faecalis Clinical Isolates
por: Lazzaro, Lorenzo M., et al.
Publicado: (2022)

Comparative activities of ampicillin and teicoplanin against Enterococcus faecalis isolates
por: Zacharopoulos, Georgios V., et al.
Publicado: (2023)

1826. Comparative Use of Vancomycin versus Ampicillin for Blood Stream Infections Caused by Ampicillin-susceptible Enterococcus faecalis
por: Phan, Michaele, et al.
Publicado: (2022)

Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
por: Herrera-Hidalgo, Laura, et al.
Publicado: (2021)

273. Comparative Effectiveness of Ampicillin in the Treatment of Enterococcus faecalis Bloodstream Infections in Patients With Cancer
por: Sanchez, J P, et al.
Publicado: (2020)

Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review
por: Marino, Andrea, et al.
Publicado: (2021)

Pheromone Activity after Stimulation with Ampicillin in a Plasmid-Free Enterococcus faecalis Strain
por: Arellano-Galindo, José, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients
por: Setiawan, Eko, et al.
Publicado: (2023)

In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance
por: Pasticci, Maria Bruna, et al.
Publicado: (2008)

Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score–Matched, Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2021)

Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
por: Mirna, Moritz, et al.
Publicado: (2021)

700. Ampicillin-Ceftriaxone Versus Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched,Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2020)

Successful Treatment of High-Level Aminoglycoside-Resistant Enterococcus faecalis Bacteremia in a Preterm Infant with Ampicillin and Cefotaxime
por: Tam, Jennifer, et al.
Publicado: (2018)

Lipid-Polymer Hybrid Nanoparticles Enhance the Potency of Ampicillin against Enterococcus faecalis in a Protozoa Infection Model
por: Tan, Chuan Hao, et al.
Publicado: (2021)

1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022)

The Times They Are A-Changin’
por: Cypress, Marjorie
Publicado: (2015)

For the times they are a-changin’?
por: Reekers, Jim A.
Publicado: (2019)

The times, they are a‐changin'
por: van Es, Sam W.
Publicado: (2022)

2173. Activity of Ceftobiprole Against Enterococcus faecalis Clinical Isolates From the United States (2016–2020), Including Those From Difficult-to-Treat Infections
por: Mendes, Rodrigo E, et al.
Publicado: (2023)

Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review
por: Marino, Andrea, et al.
Publicado: (2022)

Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022)

Effect of sub-inhibitory concentrations of antibiotics on biofilm formation and expression of virulence genes in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis
por: Caixeta Magalhães Tibúrcio, Aline Andréia, et al.
Publicado: (2022)

Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022)

Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study
por: Ramos-Martínez, Antonio, et al.
Publicado: (2020)

Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)

Recurrent Enterococcus faecalis Endophthalmitis
por: Noh, Gwang Myeong, et al.
Publicado: (2019)

1825. Comparative Effectiveness of Ampicillin versus Vancomycin or Daptomycin for the Treatment of Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections
por: Chua, Hubert C, et al.
Publicado: (2022)

Diabetic foot disease: “The Times They are A Changin’ ”
por: Bus, Sicco A., et al.
Publicado: (2020)

Paediatric lung imaging: the times they are a-changin'
por: Tiddens, Harm A.W.M, et al.
Publicado: (2018)

IgA Nephropathy: “The Times They Are a-Changin”
por: Glassock, Richard J.
Publicado: (2021)

Genome-Wide Identification of Ampicillin Resistance Determinants in Enterococcus faecium
por: Zhang, Xinglin, et al.
Publicado: (2012)

Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias
por: Horner, Carolyne, et al.
Publicado: (2021)

Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019)

Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

The times they are a‐changin’: the Cachexia Conference goes annual
por: von Haehling, Stephan, et al.
Publicado: (2016)

The Times They Are A-Changin’: Heterochrony in Plant Development and Evolution
por: Buendía-Monreal, Manuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5567ol1kformhkrdn3ue9oiqs7